Letrocam-2.5 Tablet

Letrozole 2.5 mg Tablets — Aromatase Inhibitor

Letrocam-2.5 Tablet — Letrozole 2.5 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Letrozole 2.5 mg
Dosage Form Tablet
Pack Type Alu-Alu Blister
Pack Size 10 x 10 Tablets
MRP ₹ 1900
Therapy Oncology / Gynaecology / Fertility — Non-Steroidal Aromatase Inhibitor
Storage Store below 30 °C in a dry place, protected from light and moisture.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Letrocam-2.5 Tablet

Letrocam-2.5 Tablet contains Letrozole 2.5 mg — the standard dose for adjuvant therapy of hormone-receptor-positive breast cancer in post-menopausal women, and (off-label) for ovulation induction in PCOS where it has been shown superior to clomiphene.

Most major oncology guidelines (NCCN, ESMO) recommend Letrozole among first-line aromatase inhibitors for post-menopausal ER+ breast cancer.

Manufactured by Trumac Healthcare under WHO-GMP. Available for monopoly-based PCD pharma franchise and third-party manufacturing.

Indications

  • Adjuvant therapy of HR+ breast cancer (post-menopausal)
  • Metastatic HR+ breast cancer
  • Ovulation induction in PCOS (off-label)
  • Endometrial cancer (selected cases)
  • Endometriosis (selected cases)

Mechanism of Action

Letrozole is a third-generation non-steroidal aromatase inhibitor — reversibly blocks the enzyme aromatase (CYP19A1) which converts androgens to oestrogens. Reduces circulating oestradiol by >98% in post-menopausal women. Also used in PCOS for ovulation induction (off-label, evidence-supported).

Dosage & Administration

Breast cancer: 2.5 mg once daily continuously. Ovulation induction: 2.5–7.5 mg days 3–7 of cycle.

Side Effects

Hot flushes, arthralgia, fatigue, headache, bone loss (long-term — monitor BMD), hypercholesterolaemia.

Contraindications & Precautions

Pre-menopausal women (without ovarian suppression), pregnancy, lactation, severe hepatic impairment, hypersensitivity.

Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise & Third-Party Manufacturing
Letrocam-2.5 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Letrocam-2.5 Tablet used for?

Letrocam-2.5 Tablet contains Letrozole 2.5 mg. Used as per the indications described above.

How should Letrocam-2.5 Tablet be taken?

As directed by your physician. Complete the prescribed course.

Is Letrocam-2.5 Tablet available for PCD pharma franchise?

Yes, Trumac Healthcare offers Letrocam-2.5 Tablet on monopoly-based PCD pharma franchise and for third-party manufacturing.

How should Letrocam-2.5 Tablet be stored?

Store below 30 °C in a dry place, protected from light and moisture.

Is Letrocam-2.5 Tablet WHO-GMP certified?

Yes, manufactured in WHO-GMP and DCGI-compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.